v3.24.2
REVENUE - Schedule of Disaggregated Revenue (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Disaggregation of Revenue [Line Items]        
Total net product sales $ 178,023 $ 169,467 $ 345,140 $ 329,808
EXPAREL        
Disaggregation of Revenue [Line Items]        
Total net product sales 136,852 135,127 269,282 265,535
ZILRETTA        
Disaggregation of Revenue [Line Items]        
Total net product sales 30,707 29,261 56,546 53,595
iovera°        
Disaggregation of Revenue [Line Items]        
Total net product sales 5,674 4,384 10,704 8,385
Bupivacaine liposome injectable suspension        
Disaggregation of Revenue [Line Items]        
Total net product sales 3,154 695 5,679 1,383
Total net product sales        
Disaggregation of Revenue [Line Items]        
Total net product sales $ 176,387 $ 169,467 $ 342,211 $ 328,898